Abstract
No public abstract is available from the verified source records.
Kelsey Lecerf, Kasey Strothman
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
2020 focused updates to the asthma management guidelines: a report from the national Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group
10.1016/j.jaci.2020.10.003 · 2020
Short-acting β-agonist use and its ability to predict future asthma-related outcomes
10.1016/j.anai.2012.08.014 · 2012
Inhaled reliever therapies for asthma: a systematic review and meta-analysis
10.1001/jama.2024.22700 · 2025
Unresolved referenced work
2025
Association of inhaled corticosteroids and long-acting β-Agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis
10.1001/jama.2018.2769 · 2018
Evaluation of budesonide-formoterol for maintenance and reliever therapy among patients with poorly controlled asthma: a systematic review and meta-analysis
10.1001/jamanetworkopen.2022.0615 · 2022
Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma
10.1378/chest.130.6.1733 · 2006
Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme
10.1183/13993003.01872-2019 · 2020
Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial
10.1038/s41533-017-0032-z · 2017
Short-acting Beta-2-Agonist exposure and severe asthma exacerbations: SABINA findings from Europe and North America
10.1016/j.jaip.2022.02.047 · 2022
A practical guide to implementing SMART in asthma management
10.1016/j.jaip.2021.10.011 · 2022
Optimizing pediatric asthma management: implementation and evaluation of anti-inflammatory reliever and single maintenance and reliever therapies
10.1016/j.jaip.2025.05.004 · 2025
Beginning to address an implementation gap in asthma: clinicians’ views of prescribing reliever budesonide-formoterol inhalers and SMART in the United States
10.1016/j.jaip.2023.05.023 · 2023
No additional external references are available.